Emerging factors in the progression of cancer-related pain.

Abstract

Most cancer patients experience severe pain during their disease course, and the management of cancer pain is a major challenge for patients and the healthcare team. Many diverse translational models of cancer pain in recent years have improved our understanding of cancer-related pain. Cancer and associated cells in the cancer microenvironment may release various peripheral mediators, including ATP, formaldehyde, protons, proteases, endothelin, bradykinin, TNF and NGF, that result in the activation and/or sensitization of peripheral and central neurons, that contribute to the clinical manifestations of cancer-related pain. Identification of these mediators and the peripheral and central mechanisms by which they contribute to cancer-related pain may provide novel therapeutic targets to alleviate cancer patient suffering.

DOI: 10.2217/pmt-2015-0003

Cite this paper

@article{Lam2016EmergingFI, title={Emerging factors in the progression of cancer-related pain.}, author={David K. W. Lam}, journal={Pain management}, year={2016}, volume={6 5}, pages={487-96} }